ENORM BioFactory A/S

ENORM BioFactory A/S is a Danish company focused on sustainable biotechnology, specializing in the production of Black Soldier Fly larvae for use in animal feed and potential human consumption, enhancing protein sources in agriculture. Founded in 2017, ENORM BioFactory A/S operates in Denmark and focuses on insect-based protein production. The company has undergone strategic growth with a recent deal in January 2022 that secured funding for a new protein farm and refinery. The founder's history is not detailed in the current information.

ENORM BioFactory has raised a total of 2 funding rounds, the most recent being a venture funding round led by Dansk Landbrugs Grovvareselskab a. m. b. a.

for an undisclosed amount, contributing to a total of EUR 50 million in equity and debt funding. ENORM BioFactory A/S produces Black Soldier Fly larvae, offering insect meal and insect oil as sustainable ingredients for animal feed. Insect meal contains approximately 55% protein, designed to replace traditional protein feeds in aquaculture and livestock. Insect oil, high in lauric acid, serves as a nutritional supplement for various animal groups.

The products target clients in the agricultural and food sectors, primarily in Europe and North America, aiding in their sustainability efforts. ENORM BioFactory A/S generates revenue through B2B transactions, supplying insect meal and insect oil to stakeholders in the feed and agricultural sectors. The company engages in bulk sales agreements to create ongoing partnerships with clients requiring sustainable protein sources. Their operational capacity allows for the production of 100 tons of living larvae daily, supporting the demand from their client base.

The latest reported EBITDA for 2023 stands at EUR -2,773,645. 40. ENORM BioFactory A/S aims to expand its product offerings with new designs and launches, leveraging recent funding to build a protein farm and refinery, which is expected to commence operations in early 2023. The company targets expansion into new markets across Europe and North America, enhancing their reach in the agricultural sector.

The funding received in January 2022 will primarily support these initiatives, aligning with their strategy to enhance sustainable protein production.